James Burke, MD

Trials

Studies that name James Burke, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:03 UTC. Open this list on ClinicalTrials.gov

• N/A
  NCT01730430 · Cerebrospinal Fluid (CSF) Biomarkers Alzheimer's Disease (AD) and Non-AD Dementias

  Duke University · completed · Alzheimer's Disease, Dementias · principal investigator
• Ph2
  NCT01636284 · A Phase 2a Study of Modified Vaccinia Virus to Treat Sorafenib-naïve Advanced Liver Cancer

  Jennerex Biotherapeutics · completed · Hepatocellular Carinoma · study director
• Ph1/Ph2
  NCT01394939 · Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma

  Jennerex Biotherapeutics · completed · Colorectal Carcinoma, CRC · study director
• Ph2
  NCT01387555 · A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib

  Jennerex Biotherapeutics · completed · Hepatocellular Carcinoma, Liver Cancer, HCC · study director
• Ph2
  NCT00516841 · A Phase 2, Single-Arm Study of Volociximab Monotherapy in Subjects With Platinum-Resistant Advanced Epithelial Ovarian Cancer or Primary Peritoneal Cancer

  Facet Biotech · terminated · Ovarian Cancer, Peritoneal Neoplasms · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 13:03 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 19 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.